Tracking malaria cases and prevention impact in Ugandan communities
Surveillance and Impact Evaluation Project
This project uses detailed clinic records and community surveys to track malaria trends and how prevention and treatments are working for people in Uganda.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11401052 on NIH RePORTER |
What this research studies
You or your local clinic may be part of a network where each outpatient visit is recorded electronically and regular community surveys are done around 42 health facilities across Uganda. The team links individual-level clinic data with community survey results to get timely, local information on who gets malaria, which drugs are used, and how well prevention measures are working. Data are collected continuously at participating facilities rather than relying only on infrequent national surveys, so changes can be spotted sooner. The program is run in collaboration with Uganda’s National Malaria Control Division to guide local policy and resource decisions.
Who could benefit from this research
Good fit: Ideal candidates are people living in the communities served by the 42 participating Ugandan health facilities, especially outpatients with fever or suspected malaria.
Not a fit: People living outside the selected regions or who do not seek care at participating facilities are unlikely to be directly included or see immediate benefits.
Why it matters
Potential benefit: If successful, the project could help direct prevention and treatment resources to the communities that need them most, reducing malaria cases and improving care.
How similar studies have performed: Similar enhanced surveillance efforts have helped inform malaria control policies and reduce disease in some areas, though scaling and sustainability remain challenges.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Nankabirwa, Joaniter Immaculate — University of California, San Francisco
- Study coordinator: Nankabirwa, Joaniter Immaculate
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.